Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Chang, Jennifer J; Mohtashemi, Neaka; Bhattacharya, Debika

Chang, Jennifer J; Mohtashemi, Neaka; Bhattacharya, Debika.

Affiliation

Chang JJ; UCLA CARE Center, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, 37-121 CHS, Los Angeles, CA, 90095, USA.
Mohtashemi N; Department of Infectious Diseases, Kaiser Permanente at Los Angeles Medical Center, 1505 N. Edgemont St., 2nd Floor, Los Angeles, CA, 90027, USA.
Bhattacharya D; UCLA CARE Center, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, 37-121 CHS, Los Angeles, CA, 90095, USA.

Curr HIV/AIDS Rep ; 15(2): 172-181, 2018 04.

Article in En | MEDLINE | ID: mdl-29572624

Subject(s)

Antiviral Agents/therapeutic use; HIV Infections/complications; Hepatitis B Antibodies/blood; Hepatitis B/complications; Hepatitis C/complications; HIV Infections/drug therapy; Hepatitis B/drug therapy; Hepatitis C/drug therapy; Humans

Key words

DAA; HCV treatment; HIV infection; HIV/HCV; Isolated anti-HBc; Occult HBV

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / Hepatitis C / Hepatitis B / Hepatitis B Antibodies Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: AIDS Rep Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2018 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google